Demonstrações financeiras detalhadas de Mesa Laboratories, Inc. (MLAB): demonstração de resultados, balanço patrimonial e fluxo de caixa. Acompanhe a evolução de margens, dívida, liquidez e rentabilidade ano a ano com até 20 anos de histórico.
Resumo da Análise
Mesa Laboratories, Inc. registou receitas de $249.1M no último exercício, com um CAGR de 5 anos de 13.2%. O lucro líquido atingiu $6.7M, com CAGR de 5 anos de 15.4%.
Margens dos últimos 12 meses: margem bruta 66.0%, margem operacional 9.0%, margem líquida 1.9%. O fluxo de caixa livre cresceu a CAGR de 2.4% em 5 anos.
Ao preço atual de $125.29, MLAB negocia a um P/L de 145.69 e um ROE de 2.59%. A capitalização de mercado é de $701M.
Demonstração de Resultados (10 anos)
| Ano | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Receita | $93.7M | $96.2M | $103.1M | $117.7M | $133.9M | $184.3M | $219.1M | $216.2M | $241.0M | $249.1M |
| Custo da Receita | $40.4M | $41.6M | $42.2M | $52.3M | $46.9M | $75.2M | $85.4M | $82.9M | $90.1M | $90.9M |
| Lucro Bruto | $53.2M | $54.6M | $60.9M | $65.4M | $87.0M | $109.1M | $133.7M | $133.2M | $150.9M | $158.3M |
| P&D | $4.2M | $3.5M | $3.5M | $6.4M | $10.4M | $15.8M | $20.5M | $19.3M | $19.5M | $20.3M |
| Despesas Gerais e Administrativas | $32.8M | $35.1M | $39.6M | $51.1M | $64.3M | $88.6M | $109.9M | $111.5M | $115.0M | $119.5M |
| Despesas Operacionais | $36.9M | $38.6M | $43.1M | $57.4M | $74.7M | $104.4M | $130.4M | $405.3M | $134.5M | $139.8M |
| Lucro Operacional | $16.3M | $2.2M | $9.8M | $7.9M | $12.4M | $4.7M | $3.3M | -$272.1M | $16.3M | $18.5M |
| EBITDA | $25.1M | $9.8M | $18.1M | $22.4M | $28.0M | $32.5M | $37.5M | -$238.4M | $42.3M | $35.3M |
| Despesas com Juros | 0 | $1.9M | 0 | $5.5M | $8.0M | $3.9M | $4.8M | $5.7M | $11.9M | $10.7M |
| Lucro Antes de Impostos | $14.3M | $301000 | $8.6M | $3.9M | $2.3M | $3.6M | -$389000 | -$275.6M | $6.0M | $12.0M |
| Imposto | $3.1M | $3.3M | $1.1M | $2.1M | -$971000 | $1.7M | -$1.3M | -$21.4M | $7.9M | $5.3M |
| Lucro Líquido | $11.2M | -$3.0M | $7.5M | $1.8M | $3.3M | $1.9M | $930000 | -$254.2M | -$2.0M | $6.7M |
| LPA | $3.04 | $-0.79 | $1.95 | $0.32 | $0.66 | $0.36 | $0.17 | $-47.20 | $-0.36 | $1.22 |
| LPA Diluído | $2.91 | $-0.79 | $1.86 | $0.31 | $0.64 | $0.35 | $0.17 | $-47.20 | $-0.36 | $1.21 |
| Ações em Circulação (Diluídas) | $3.8M | $3.8M | $4.0M | $4.4M | $5.1M | $5.3M | $5.4M | $5.4M | $5.4M | $5.6M |
Demonstração de Resultados (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Receita | $60.7M | $65.1M | $63.7M | $60.1M |
| Lucro Bruto | $37.3M | $41.8M | $46.6M | $39.0M |
| Lucro Operacional | $4.7M | $8.0M | $2.7M | $7.0M |
| EBITDA | $10.7M | $13.3M | $4.2M | $12.4M |
| Lucro Líquido | $2.5M | $3.6M | -$4.1M | $2.8M |
| LPA | $0.45 | $0.66 | $-0.75 | $0.50 |
| LPA Diluído | $0.45 | $0.65 | $-0.75 | $0.49 |
Balanço (10 anos)
| Ano | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Caixa e Equivalentes | $5.8M | $5.5M | $10.2M | $81.4M | $263.9M | $49.3M | $32.9M | $28.2M | $27.3M | $26.9M |
| Investimentos de Curto Prazo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Contas a Receber | $14.3M | $14.3M | $12.5M | $21.1M | $23.8M | $41.2M | $42.6M | $39.1M | $42.0M | $44.1M |
| Estoque | $13.9M | $9.2M | $6.8M | $14.2M | $11.2M | $24.6M | $34.6M | $32.7M | $25.4M | $26.4M |
| Ativos Circulantes | $35.8M | $32.0M | $33.6M | $122.8M | $303.7M | $124.3M | $119.0M | $109.4M | $102.7M | $106.3M |
| Imobilizado | $26.0M | $23.6M | $22.2M | $22.1M | $22.0M | $28.6M | $28.1M | $41.4M | $32.3M | $48.1M |
| Ágio | $72.2M | $65.5M | $66.4M | $141.5M | $160.8M | $291.2M | $286.4M | $180.1M | $181.8M | $186.9M |
| Ativos Intangíveis | $37.8M | $42.9M | $33.2M | $119.9M | $111.7M | $250.1M | $216.8M | $113.8M | $96.9M | $83.3M |
| Ativos Totais | $171.7M | $164.1M | $156.8M | $420.2M | $601.5M | $707.4M | $661.8M | $446.8M | $433.3M | $427.7M |
| Contas a Pagar | $2.2M | $2.4M | $2.9M | $3.4M | $4.5M | $7.9M | $6.1M | $6.0M | $5.7M | $4.9M |
| Dívida de Curto Prazo | $1.1M | $1.6M | $2.1M | 0 | 0 | 0 | 0 | 0 | $101.0M | $5.6M |
| Passivos Circulantes | $16.6M | $17.3M | $23.7M | $26.0M | $32.6M | $48.1M | $43.4M | $44.3M | $164.0M | $61.9M |
| Dívida de Longo Prazo | $53.7M | $44.6M | $20.6M | $140.3M | $145.7M | $218.4M | $183.3M | $221.7M | $76.9M | $145.9M |
| Passivos Totais | $73.9M | $64.7M | $45.5M | $200.2M | $195.2M | $313.6M | $268.4M | $301.4M | $273.5M | $241.5M |
| Reservas | $73.7M | $68.3M | $73.3M | $71.9M | $72.5M | $76.7M | $74.2M | -$183.5M | -$188.9M | -$185.7M |
| Patrimônio Líquido | $97.8M | $99.4M | $111.3M | $220.0M | $406.2M | $393.8M | $393.5M | $145.4M | $159.8M | $186.2M |
| Dívida Total | $54.8M | $46.3M | $22.7M | $141.4M | $146.7M | $221.1M | $186.1M | $231.3M | $181.5M | $168.8M |
| Dívida Líquida | $49.0M | $40.8M | $12.6M | $60.0M | -$117.2M | $171.8M | $153.2M | $203.1M | $154.2M | $141.9M |
| Capital de Giro | $19.2M | $14.7M | $10.0M | $96.8M | $271.2M | $76.3M | $75.6M | $65.0M | -$61.3M | $44.4M |
Balanço (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caixa e Equivalentes | $20.4M | $29.0M | $26.9M | $30.7M |
| Ativos Totais | $430.4M | $434.8M | $427.7M | $419.2M |
| Passivos Totais | $251.9M | $248.2M | $241.5M | $230.5M |
| Patrimônio Líquido | $178.5M | $186.7M | $186.2M | $188.8M |
| Dívida Total | $190.4M | $181.0M | $155.2M | $101.4M |
Fluxo de Caixa (10 anos)
| Ano | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Lucro Líquido | $11.2M | -$3.0M | $7.5M | $1.3M | $3.3M | $1.9M | $930000 | -$254.2M | -$2.0M | $6.7M |
| Depreciação e Amortização | $8.7M | $9.5M | $9.4M | $13.0M | $17.7M | $25.1M | $33.1M | $31.6M | $24.5M | $23.3M |
| Compensação em Ações | $1.4M | $1.7M | $4.2M | $5.5M | $9.3M | $11.4M | $12.5M | $11.9M | $13.1M | $17.9M |
| Variação Capital de Giro | -$13.0M | $3.2M | $7.9M | -$3.1M | $5.3M | -$7.2M | -$17.1M | $6.0M | $6.9M | -$5.0M |
| Fluxo de Caixa Operacional | $7.8M | $24.8M | $30.6M | $26.6M | $37.1M | $39.2M | $28.0M | $44.1M | $46.8M | $42.8M |
| CapEx | -$11.6M | -$2.8M | -$1.3M | -$1.5M | -$2.0M | -$4.4M | -$4.5M | -$2.6M | -$4.5M | -$3.2M |
| Aquisições | -$6.8M | -$15.5M | -$4.8M | -$184.1M | 0 | -$300.8M | -$5.0M | -$78.7M | 0 | 0 |
| Recompra de Ações | 0 | 0 | -$5.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagos | -$2.4M | -$2.4M | -$2.5M | -$2.7M | -$3.2M | -$3.3M | -$3.4M | -$3.4M | -$3.5M | -$3.5M |
| Fluxo de Caixa Livre | -$3.9M | $22.0M | $29.3M | $25.1M | $35.1M | $34.8M | $23.4M | $41.6M | $42.3M | $39.6M |
Fluxo de Caixa (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Fluxo de Caixa Operacional | $8.2M | $18.8M | $14.0M | $14.7M |
| CapEx | -$1.1M | -$732000 | $2.8M | -$559000 |
| Fluxo de Caixa Livre | $7.1M | $18.0M | $16.8M | $14.2M |
| Dividendos Pagos | -$882000 | -$884000 | -$884000 | -$884000 |
| Compensação em Ações | $3.8M | $3.4M | -$11.1M | $2.4M |
Crescimento e Margens (10 anos)
| Ano | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Crescimento Receita (anual) | | +2.7% | +7.2% | +14.1% | +13.8% | +37.6% | +18.8% | -1.3% | +11.5% | +3.4% |
| Crescimento Lucro Líquido (anual) | | -126.5% | +352.7% | -76.2% | +84.1% | -42.9% | -50.3% | -27438.3% | +99.2% | +440.0% |
| Crescimento LPA (anual) | | -126.0% | +346.8% | -83.6% | +106.2% | -45.5% | -52.8% | -27864.7% | +99.2% | +438.9% |
| Variação de Ações (anual) | | -1.9% | +7.0% | +8.4% | +17.2% | +4.1% | +0.5% | +0.5% | +0.8% | +2.5% |
| Crescimento FCF (anual) | | +671.1% | +33.1% | -14.4% | +40.0% | -0.8% | -32.6% | +77.3% | +1.8% | -6.4% |
| Margem Bruta | 56.8% | 56.8% | 59.1% | 55.5% | 65.0% | 59.2% | 61.0% | 61.6% | 62.6% | 63.5% |
| Margem Operacional | 17.4% | 2.3% | 9.5% | 6.7% | 9.2% | 2.6% | 1.5% | -125.9% | 6.8% | 7.4% |
| Margem EBITDA | 26.7% | 10.2% | 17.5% | 19.0% | 20.9% | 17.6% | 17.1% | -110.3% | 17.6% | 14.2% |
| Margem Líquida | 11.9% | -3.1% | 7.3% | 1.5% | 2.4% | 1.0% | 0.4% | -117.6% | -0.8% | 2.7% |
| Margem FCF | -4.1% | 22.9% | 28.4% | 21.3% | 26.2% | 18.9% | 10.7% | 19.2% | 17.6% | 15.9% |
| Taxa Efetiva de Imposto | 21.8% | 1084.1% | 13.2% | 54.0% | -42.2% | 47.6% | 339.1% | 7.8% | 133.1% | 44.1% |
Dados por Ação (10 anos)
| Ano | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| FCF por Ação | $-1.00 | $5.84 | $7.26 | $5.73 | $6.85 | $6.52 | $4.37 | $7.72 | $7.79 | $7.11 |
| Dividendo por Ação | $0.61 | $0.64 | $0.61 | $0.62 | $0.62 | $0.63 | $0.64 | $0.64 | $0.64 | $0.63 |
| Ações em Circulação (Básicas) | $3.7M | $3.7M | $3.8M | $4.2M | $5.0M | $5.2M | $5.3M | $5.4M | $5.4M | $5.5M |
O que olhar em Saúde / Farma
O pipeline de I+D é o ativo invisível. Patentes a caducar = receitas a evaporar. Olha inovação e fluxo de caixa.
- I+D / Receita — Indica investimento em pipeline futuro. Farma séria reinveste 15-20%
- Crescimento EPS 5 anos — Após expiração de patentes, ainda crescem?
- Margem bruta — Farma de marca >70%. Genéricos muito mais baixo — define o tipo de negócio
- FCF / Net Income — Qualidade do lucro — farma grande deveria converter >90%
- ROIC — Capital reinvestido com eficiência — chave em farma por ciclos longos de I+D
- Dívida líquida / EBITDA — Aquisições farmacêuticas geram muita dívida — atenção ao pós-M&A
- P/E vs histórico 10 anos próprio — A melhor comparação é com o próprio histórico, não com pares
Rentabilidade
| Retorno sobre patrimônio | 2.59% |
| Retorno sobre capital investido | 3.05% |
| Retorno sobre ativos | 1.14% |
| Margem bruta | 65.99% |
| Margem operacional | 9.00% |
| Margem líquida | 1.92% |
Saúde financeira
| Dívida / Patrimônio | 0.54 |
| Liquidez corrente | 2.07 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 1.45 |
Índices Chave (10 anos)
| Ano | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| P/L | 40.36 | -187.90 | 117.38 | 706.53 | 368.94 | 708.00 | 1027.82 | -2.37 | -329.61 | 72.48 |
| P/VP | 4.61 | 5.60 | 7.89 | 4.32 | 2.98 | 3.37 | 2.36 | 4.15 | 4.03 | 2.62 |
| P/V | 4.82 | 5.79 | 8.52 | 8.07 | 9.04 | 7.21 | 4.24 | 2.79 | 2.67 | 1.96 |
| Margem Bruta | 56.8% | 56.8% | 59.1% | 55.5% | 65.0% | 59.2% | 61.0% | 61.6% | 62.6% | 63.5% |
| Margem Operacional | 17.4% | 2.3% | 9.5% | 6.7% | 9.2% | 2.6% | 1.5% | -125.9% | 6.8% | 7.4% |
| Margem Líquida | 11.9% | -3.1% | 7.3% | 1.5% | 2.4% | 1.0% | 0.4% | -117.6% | -0.8% | 2.7% |